Biological, Chemical, and Radiological Weapons Countermeasures Research Act of 2002
Latest action · Oct 17, 2002 Read twice and referred to the Committee on Finance.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedOct 17, 2002
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Requires private sector entities that are engaged in certain research to register with the Department of Homeland Security if they wish to benefit from various tax, patent, procurement, liability limitations, and other incentives established under this Act. Classifies such research as: (1) countermeasures; (2) diagnostics to detect, identify, or analyze biological agents or toxins ("diagnostics"); and (3) research tools used in the laboratory ("research tools") that enable the rapid and effective development of countermeasures.
Establishes in the Treasury of the United States a "Terror Weapon Countermeasure Purchase Fund (TWCPF)" to purchase, and provide adequate payment for, countermeasures, diagnostics, and research tools.
Extends market exclusivity for new drugs that are countermeasures.
Directs the Secretary to enter into agreements to indemnify and defend persons or entities: (1) involved in the research, development, and production of countermeasures, diagnostics, or research tools purchased under the TWCPF; or (2) who face civil actions arising from human trials and research, development, and production of countermeasures certified under this Act.
Cosponsors 1
Members who signed on, in the order they did. All signed on Oct 17, 2002.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-UT | Orrin G. Hatch | Original | Oct 17, 2002 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Finance Committee | Referred Oct 18, 2002 |
Actions 3
Everything that happened, newest first.
- Oct 17, 2002Introduced in Senate
- Oct 17, 2002Sponsor introductory remarks on measure. (CR S10716-10725)
- Oct 17, 2002Read twice and referred to the Committee on Finance.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S10716–S10728Summaries S10724 | Joseph I. Lieberman I-CT, Orrin G. Hatch R-UT | Oct 17, 2002 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to provide incentives to increase research by private sector entities to develop antivirals, antibiotics and other drugs, vaccines, microbicides, and diagnostic technologies to prevent and treat illnesses associated with a biological, chemical, or radiological weapons attack.
- Short Titles as Introduced
- Biological, Chemical, and Radiological Weapons Countermeasures Research Act of 2002
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative procedure
- Animals
- Antibiotics
- Antitrust law
- Armed Forces and National Security
- Biological warfare
- Biological weapons
- Biotechnology
- Business income tax
- Business records
- Capital gains tax
- Capital investments
- Chemical warfare
- Chemical weapons
- Clinical trials
- Commerce
- Communication in medicine
- Corporate finance
- Corporation taxes
- Department of Health and Human Services
- Diseases
- Drug approvals
- Drug industry
- EBB Terrorism
- Environmental Protection
- Factories
- Factory management
- Federal aid to medical education
- Government Operations and Politics
- Government paperwork
- Government trust funds
- Governmental investigations
- Health
- Higher education
- Indemnity
- Intellectual property
- International Affairs
- International cooperation
- Laboratories
- Laboratory animals
- Law
- Liability (Law)
- License agreements
- Limited partnerships
- Medical screening
- Medical technology
- Medical tests
- Microbiological research
- Nonprofit hospitals
- Nonprofit organizations
- Nuclear terrorism
- Nuclear warfare
- Nuclear weapons
- Orphan drugs
- Patent licenses
- Patents
- Pharmaceutical research
- Radiation safety
- Radioactive decontamination
- Research and development
- Science, Technology, Communications
- Smallpox
- Social Welfare
- Tax credits
- Tax exclusion
- Tax incentives
- Taxation
- Teaching hospitals
- Technology transfer
- Terrorism
- Vaccination
- Vaccines
- Virus diseases
- Weapons of mass destruction
Text 1
Each version as it was printed, newest first.
- Oct 17, 2002Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
